Periodic constriction of vessels to treat ischemic tissue
First Claim
Patent Images
1. A method for treating ischemia in a patient, the method comprising:
- depositing a layer of polymer on the luminal surface of a target vessel; and
injecting microspheres containing a vasoconstrictor into the patient, wherein the microspheres are adapted to attach to the layer of polymer and release the vasoconstrictor in situ adjacent to the layer of polymer.
2 Assignments
0 Petitions
Accused Products
Abstract
Brief periods of occlusion of blood flow in an otherwise open target vessel adjacent to vessels supplying blood to an ischemic region are caused by periodic administration of a therapeutically effective amount of a vasoconstrictor. It is anticipated these brief periods of occlusion will induce the enlargement of collateral vessels, causing increased blood flow to the ischemic region.
311 Citations
15 Claims
-
1. A method for treating ischemia in a patient, the method comprising:
-
depositing a layer of polymer on the luminal surface of a target vessel; and
injecting microspheres containing a vasoconstrictor into the patient, wherein the microspheres are adapted to attach to the layer of polymer and release the vasoconstrictor in situ adjacent to the layer of polymer. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
further comprising injecting receptor molecules into the patient, the receptor molecules comprising second members of the affinity pair, wherein the second members of the receptor molecules are adapted to engage the first members of the layer of polymer and the microspheres so that the microspheres attach to the layer of polymer.
-
-
5. The method of claim 4, wherein the first member of the affinity pair is selected from the group consisting of biotin and analogs thereof and further wherein the second member of the affinity pair is selected from the group consisting of avidin and analogs thereof.
-
6. The method of claim 1, wherein the layer of polymer includes first members of an affinity pair, and the microspheres include second members of an affinity pair.
-
7. The method of claim 1, wherein the first members of the affinity pair are selected from the group consisting of biotin and analogs thereof and the second members of the affinity pair are selected from the group consisting of avidin and analogs thereof.
-
8. The method of claim 1, further comprising:
providing energy from an external energy source to rupture the microspheres, thereby releasing the vasoconstrictor.
-
9. The method of claim 8, wherein the energy is an ultrasound beam.
-
10. The method of claim 1, wherein the microspheres are comprised of a material selected from the group consisting of poly(DL Lactide-co-Glycolide), poly-lactic acid, polyglycolic acid, gelatin, polyester, alginate, polyethylene oxide, lipid, gas-filled liposomes, and albumin.
-
11. The method of claim 1, wherein the layer of polymer is selected from the group consisting of poly-lactic acid, poly-glycolic acid, polyphosphazenes, polyhydroxybutyric acid, poly-caprolactone, polyanhydrides, polyethylene glycol, and copolymers and mixtures thereof.
-
12. The method of claim 1, wherein the layer of polymer is deposited using a stent.
-
13. The method of claim 1, wherein the layer of polymer is deposited by paving the endoluminal surface of the target vessel with a hydrogel.
-
14. The method of claim 1, wherein the polymer or microspheres are biotinylated using photoactivatable biotin.
-
15. The method of claim 1, wherein the act of depositing a polymer comprises applying a hydrogel precursory to the target vessel and causing the polymerization of the precursor to form the layer.
Specification